Kawasaki disease is a vasculitis — an inflammation of the blood vessels — that primarily affects children under five. It was first described by Dr. Tomisaku Kawasaki in Japan in 1967, and it remains the leading cause of acquired heart disease in children in developed countries. That sounds alarming, and it should — because the treatment window is narrow and the stakes are your child's coronary arteries.
Here is what happens: the immune system, triggered by something (the exact cause is still unknown), attacks the walls of medium-sized blood vessels throughout the body. The most dangerous target is the coronary arteries — the vessels that supply blood to the heart muscle. Without treatment, about 25% of children with Kawasaki disease develop coronary artery aneurysms, which are weakened, ballooned-out areas of those arteries. These aneurysms can cause blood clots, heart attacks, or sudden death — not just during the illness, but years or decades later.
With treatment — specifically intravenous immunoglobulin (IVIG) given within 10 days of fever onset — that 25% drops to less than 5%. That is why recognizing Kawasaki disease early is so critical. Every day of delay increases the risk of permanent heart damage.
Kawasaki disease is not an infection. Antibiotics will not treat it. It is not contagious. It is most common in children of Asian descent (particularly Japanese, Korean, and Chinese heritage), but it occurs in all races and ethnicities. Boys are affected about 1.5 times more often than girls. The peak age is 18-24 months, and about 80% of cases occur in children under five.